Search
for

    Sort by

    Research 721–750 of 1000+

    1. Economic Issues in the Treatment of BPH European Urology Supplements · 2006 · 11 citations
    2. The Benefits of Dual Inhibition of 5α Reductase European Urology Supplements · 2006 · 4 citations
    3. Bladder cancer survival in men using 5-alpha-reductase inhibitors European Urology Supplements · 2018 · 3 citations
    4. CARI ONE Induces Anagen Phase of Telogenic Hair Follicles Through Regulation of β-Catenin, Stimulation of Dermal Papilla Cell Proliferation, and Melanogenesis Journal of Dietary Supplements · 2014 · 3 citations
    5. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006 · 2 citations
    6. C53 HAIR FOLLICLE STEM CELLS AND BONE MARROW MESENCHYMAL STEM CELLS IN BLADDER REGENERATION European Urology Supplements · 2010 · 1 citations
    7. Tamsulosin versus finasteride: effect on bother and urinary flow European Urology Supplements · 2002 · 1 citations
    8. C85. Right heart failure due to chronic thromboembolic pulmonary hypertension in systemic lupus erythematosus patient: a case report European Heart Journal Supplements · 2021
    9. C85. Right heart failure due to chronic thromboembolic pulmonary hypertension in systemic lupus erythematosus patient: a case report European Heart Journal Supplements · 2021
    10. Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial European Urology Supplements · 2019
    11. 1093 Clinical effects of dutasteride and finasteride: Are they different or equivalent? Results from record-linkage and match-paired analyses European Urology Supplements · 2013
    12. 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER European Urology Supplements · 2011
    13. 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR European Urology Supplements · 2011
    14. 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES European Urology Supplements · 2011
    15. S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION? European Urology Supplements · 2010
    16. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    17. C36 LONG TERM TREATMENT WITH FINASTERIDE IN MEN WITH LUTS - A 13 YEARS FOLLOW UP European Urology Supplements · 2010
    18. S2 PSA: RELIABLE OR NOT RELIABLE? European Urology Supplements · 2010
    19. S4 URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY European Urology Supplements · 2010
    20. S170 DOES STATINS HAVE ANY IMPACT ON THE PROGRESSION OF BPH AND LUTS WHEN COMBINED WITH FINASTERIDE European Urology Supplements · 2010
    21. S3 SERUM TRIGLYCERIDE CONCENTRATION AND RISK OF PROSTATE CANCER: A PROSPECTIVE MULTICENTER STUDY European Urology Supplements · 2010
    22. 866 Senescent fibroblasts secretome promote tumoural initiation of normal human keratinocytes through cellular activation, enhanced migration and ECM remodelling European Journal of Cancer Supplements · 2010
    23. 371 THE EFFECTIVENESS OF BIO-REGULATORY MAGNETO-LASER THERAPY OF CHRONIC PELVIC PAIN SYNDROME/CHRONIC PROSTATITIS IMA European Urology Supplements · 2010
    24. P7 p63, K14 and p53 expression in epithelial layers of tumor-distant oral mucosa in patients with oral squamous cell carcinoma European Journal of Cancer Supplements · 2010
    25. S90 Urethral PSA production after radical prostatectomy European Urology Supplements · 2009
    26. S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8) European Urology Supplements · 2009
    27. S88 Does cone beam computed tomography decrease CTV's margins in prostate cancer radiation treatment? European Urology Supplements · 2009
    28. S87 Image guided radiotherapy (IGRT) in stage III prostate cancer: analysis of acute toxicity European Urology Supplements · 2009
    29. 710 BIOMARKERS OF SUNITNIB CLINICAL RESPONSE IN METASTATIC RENAL CLEAR CELL CARCINOMA PATIENTS European Urology Supplements · 2009
    30. Effects of androgen and valproic acid treatment on androgen- dependent cell line (LnCaP-SF) European Journal of Cancer Supplements · 2008